tiprankstipranks
Trending News
More News >
Kobayashi Pharmaceutical Co Ltd (KBYPF)
OTHER OTC:KBYPF
US Market
Advertisement

Kobayashi Pharmaceutical Co (KBYPF) Stock Forecast & Price Target

Compare
6 Followers
See the Price Targets and Ratings of:

KBYPF Financial Forecast

KBYPF Earnings Forecast

Next quarter’s earnings estimate for KBYPF is $0.30 with a range of $0.30 to $0.30. The previous quarter’s EPS was $0.14. KBYPF beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 38.46% of the time in the same period. In the last calendar year KBYPF has Preformed in-line its overall industry.
Next quarter’s earnings estimate for KBYPF is $0.30 with a range of $0.30 to $0.30. The previous quarter’s EPS was $0.14. KBYPF beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 38.46% of the time in the same period. In the last calendar year KBYPF has Preformed in-line its overall industry.

KBYPF Sales Forecast

Next quarter’s sales forecast for KBYPF is $296.27M with a range of $289.68M to $304.64M. The previous quarter’s sales results were $247.01M. KBYPF beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 60.00% of the time in the same period. In the last calendar year KBYPF has Preformed in-line its overall industry.
Next quarter’s sales forecast for KBYPF is $296.27M with a range of $289.68M to $304.64M. The previous quarter’s sales results were $247.01M. KBYPF beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 60.00% of the time in the same period. In the last calendar year KBYPF has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on KBYPF
TR | OpenAI - 4o
TR | OpenAI - 4o
$37.42$39.02
Hold
4.26%
Upside
Reiterated
09/02/25
AI Generated ArticleAI Generated Article
Nomura
$36.95$34.27
Hold
-8.45%
Downside
Reiterated
06/04/25
Nomura Remains a Hold on Kobayashi Pharmaceutical Co (KBYPF)
Jefferies
$34.94
Hold
-6.66%
Downside
Reiterated
03/21/25
Jefferies Reaffirms Their Hold Rating on Kobayashi Pharmaceutical Co (KBYPF)
Morgan Stanley Analyst forecast on KBYPF
Morgan Stanley
Morgan Stanley
$38.97$40.31
Hold
7.71%
Upside
Reiterated
09/25/24
Kobayashi Pharma Co Ltd. (4967:JP) PT Raised to JPY6,000 at Morgan StanleyMorgan Stanley analyst Wakako Sato raised the price target on Kobayashi Pharma Co Ltd. (4967:JP) to JPY6,000.00 (from JPY5,800.00) while maintaining a Equalweight rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TR | OpenAI - 4o Analyst forecast on KBYPF
TR | OpenAI - 4o
TR | OpenAI - 4o
$37.42$39.02
Hold
4.26%
Upside
Reiterated
09/02/25
AI Generated ArticleAI Generated Article
Nomura
$36.95$34.27
Hold
-8.45%
Downside
Reiterated
06/04/25
Nomura Remains a Hold on Kobayashi Pharmaceutical Co (KBYPF)
Jefferies
$34.94
Hold
-6.66%
Downside
Reiterated
03/21/25
Jefferies Reaffirms Their Hold Rating on Kobayashi Pharmaceutical Co (KBYPF)
Morgan Stanley Analyst forecast on KBYPF
Morgan Stanley
Morgan Stanley
$38.97$40.31
Hold
7.71%
Upside
Reiterated
09/25/24
Kobayashi Pharma Co Ltd. (4967:JP) PT Raised to JPY6,000 at Morgan StanleyMorgan Stanley analyst Wakako Sato raised the price target on Kobayashi Pharma Co Ltd. (4967:JP) to JPY6,000.00 (from JPY5,800.00) while maintaining a Equalweight rating.
Stocks with the Highest Top Analyst Consensus in the Consumer Defensive Sector
Find stocks in the Consumer Defensive sector that are highly recommended by Top Performing Analysts.

KBYPF Analyst Recommendation Trends

Rating
Apr 25
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
6
7
12
13
11
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
7
12
13
11
In the current month, KBYPF has received 0 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. KBYPF average Analyst price target in the past 3 months is 34.27.
Each month's total comprises the sum of three months' worth of ratings.

KBYPF Stock Forecast FAQ

What is KBYPF’s average 12-month price target, according to analysts?
Based on analyst ratings, Kobayashi Pharmaceutical Co Ltd’s 12-month average price target is 34.27.
    What is KBYPF’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for KBYPF, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is KBYPF a Buy, Sell or Hold?
        Kobayashi Pharmaceutical Co Ltd has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
          What is Kobayashi Pharmaceutical Co Ltd’s price target?
          The average price target for Kobayashi Pharmaceutical Co Ltd is 34.27. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $34.27 ,the lowest forecast is $34.27. The average price target represents -8.44% Decrease from the current price of $37.43.
            What do analysts say about Kobayashi Pharmaceutical Co Ltd?
            Kobayashi Pharmaceutical Co Ltd’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
              How can I buy shares of KBYPF?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis